ALS Drug Gains FDA Approval Despite Uncertainty About Its Effectiveness | CNN
CNN — A new treatment for amyotrophic lateral sclerosis, or ALS, has been approved by the US Food and Drug Administration. The FDA announced Thursday the approval of Relyvrio, developed by Amylyx Pharmaceuticals. According to the company, the oral drug can be taken as a stand-alone therapy or alongside other treatments, and has been shown …
ALS Drug Gains FDA Approval Despite Uncertainty About Its Effectiveness | CNN Read More »